tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BDRX Stock Latest News

Biodexa’s eRapa Shows Promise for FAP Treatment
Company AnnouncementsBiodexa’s eRapa Shows Promise for FAP Treatment
9d ago
6K
BDRX
Biodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting
PremiumPress Releases
Biodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting
9d ago
BDRX
Biodexa Pharmaceuticals Seals Deal with Emtora Biosciences
PremiumCompany Announcements
Biodexa Pharmaceuticals Seals Deal with Emtora Biosciences
13d ago
6K
BDRX
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
PremiumPress Releases
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
13d ago
BDRX
Biodexa Pharmaceuticals enters into exclusive license to eRapa
PremiumThe Fly
Biodexa Pharmaceuticals enters into exclusive license to eRapa
13d ago
BDRX
Navigating Uncertainty: Biodexa Pharmaceuticals and the Impact of Geopolitical Turmoil on Pharma’s Bottom Line
PremiumCompany AnnouncementsNavigating Uncertainty: Biodexa Pharmaceuticals and the Impact of Geopolitical Turmoil on Pharma’s Bottom Line
20d ago
BDRX
Biodexa Pharmaceuticals Reports 2023 Milestones
PremiumCompany Announcements
Biodexa Pharmaceuticals Reports 2023 Milestones
20d ago
6K
BDRX
Biodexa Pharmaceuticals directors continue to adopt going concern basis
PremiumThe Fly
Biodexa Pharmaceuticals directors continue to adopt going concern basis
20d ago
BDRX
Biodexa ‘enthusiastic’ about potential in 2024 and beyond
PremiumThe Fly
Biodexa ‘enthusiastic’ about potential in 2024 and beyond
20d ago
BDRX
Biodexa reports preliminary 2023 revenue GBP 0.38M vs. GBP 0.70M last year
PremiumThe Fly
Biodexa reports preliminary 2023 revenue GBP 0.38M vs. GBP 0.70M last year
20d ago
BDRX
Biodexa says early trials of MTX110 show promise in extending life expectancy
PremiumThe Fly
Biodexa says early trials of MTX110 show promise in extending life expectancy
1M ago
BDRX
Biodexa Pharmaceuticals files to sell 1.28B ordinary shares for holders
PremiumThe Fly
Biodexa Pharmaceuticals files to sell 1.28B ordinary shares for holders
2M ago
BDRX
Biodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update
PremiumPress ReleasesBiodexa Announces Positive Top Line Phase I Clinical Trial Results for Diffuse Midline Glioma and Provides R&D Update
3M ago
BDRX
Biodexa announces results for Phase 1 study of MTX110, update for Tolimidone
PremiumThe Fly
Biodexa announces results for Phase 1 study of MTX110, update for Tolimidone
3M ago
BDRX
Alibaba downgraded, Disney upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Alibaba downgraded, Disney upgraded: Wall Street’s top analyst calls
3M ago
ZI
AXP
Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients
PremiumPress Releases
Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in Recurrent Glioblastoma Patients
3M ago
BDRX
Biodexa Pharmaceuticals reports 12 month survival in MAGIC-G1 study of MTX110
PremiumThe Fly
Biodexa Pharmaceuticals reports 12 month survival in MAGIC-G1 study of MTX110
3M ago
BDRX
Biodexa Pharmaceuticals initiated with a Buy at Ladenburg
PremiumThe Fly
Biodexa Pharmaceuticals initiated with a Buy at Ladenburg
3M ago
BDRX
Biodexa Pharmaceuticals announces allowance of U.S. patent covering tolimidone
PremiumThe Fly
Biodexa Pharmaceuticals announces allowance of U.S. patent covering tolimidone
3M ago
BDRX
Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024
PremiumPress ReleasesBiodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024
4M ago
BDRX
Biodexa Pharmaceuticals CEO issues letter to shareholders
PremiumThe Fly
Biodexa Pharmaceuticals CEO issues letter to shareholders
4M ago
BDRX
Biodexa Appoints Ann Merchant to the Board of Directors
PremiumPress Releases
Biodexa Appoints Ann Merchant to the Board of Directors
4M ago
BDRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >